» Articles » PMID: 35887634

Association Between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia

Overview
Journal J Pers Med
Date 2022 Jul 27
PMID 35887634
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we investigated the impact of inflammatory cytokines on the cognitive performance of patients with schizophrenia. The included patients met the criteria for schizophrenia spectrum disorder and were aged between 15 and 40 years, with a duration of illness ≤1 year. Plasma tumor necrosis factor (TNF)-α; interferon-γ; and interleukin (IL)-1β, IL-6, IL-8, IL-10, and IL-12 levels were measured. A computerized neurocognitive battery, measures for social cognitive function, and clinical measures were administered. A total of 174 patients with first-episode psychosis were enrolled. The TNF-α level was negatively correlated with scores on the digit span, verbal learning, and Wisconsin card sorting tests, and the number of correct responses on the continuous performance test (CR-CPT), whereas a positive correlation was detected with the trail making test (TMT)-B time. The interferon-γ level was negatively correlated with performance on the false belief and visual learning tests. The IL-1β level was positively correlated with the TMT-A time and CPT reaction time, whereas it was negatively correlated with the CR-CPT and performance on the visual learning and social cognitive tests. The IL-12 level was negatively correlated with the CR-CPT and false belief test. Our results suggest that proinflammatory cytokines are associated with cognitive impairment in patients with schizophrenia.

Citing Articles

Plasma microRNAs Associate Positive, Negative, and Cognitive Symptoms with Inflammation in Schizophrenia.

Miyano T, Hirouchi M, Yoshimura N, Hattori K, Mikkaichi T, Kiyosawa N Int J Mol Sci. 2025; 25(24.

PMID: 39769285 PMC: 11676741. DOI: 10.3390/ijms252413522.


Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients.

Cui L, Cai L, Na W, Jia R, Zhu J, Pan X World J Psychiatry. 2024; 14(12):1804-1814.

PMID: 39704351 PMC: 11622020. DOI: 10.5498/wjp.v14.i12.1804.


Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits.

Guo T, Chen L, Luan L, Yang M, Zhang X, Yang H BMC Psychiatry. 2024; 24(1):811.

PMID: 39548412 PMC: 11566147. DOI: 10.1186/s12888-024-06288-9.


Association between suicidal ideation and cognitive function in young patients with schizophrenia spectrum disorder.

Kim J, Baek S, Kim H, Kim J, Kang H, Ryu S Front Psychiatry. 2023; 14:1276511.

PMID: 37965366 PMC: 10641781. DOI: 10.3389/fpsyt.2023.1276511.


Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia.

Kim H, Baek S, Kim J, Ryu S, Lee J, Kim J Schizophrenia (Heidelb). 2023; 9(1):68.

PMID: 37794014 PMC: 10550944. DOI: 10.1038/s41537-023-00398-1.


References
1.
Xiao X, Xu X, Li F, Xie G, Zhang T . Anti-inflammatory treatment with β-asarone improves impairments in social interaction and cognition in MK-801 treated mice. Brain Res Bull. 2019; 150:150-159. DOI: 10.1016/j.brainresbull.2019.05.017. View

2.
Deakin B, Suckling J, Barnes T, Byrne K, Chaudhry I, Dazzan P . The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial. Lancet Psychiatry. 2018; 5(11):885-894. PMC: 6206257. DOI: 10.1016/S2215-0366(18)30345-6. View

3.
Asevedo E, Gadelha A, Noto C, Mansur R, Zugman A, Belangero S . Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. J Psychiatr Res. 2013; 47(10):1376-82. DOI: 10.1016/j.jpsychires.2013.05.032. View

4.
Dickerson S, Kemeny M, Aziz N, Kim K, Fahey J . Immunological effects of induced shame and guilt. Psychosom Med. 2004; 66(1):124-31. DOI: 10.1097/01.psy.0000097338.75454.29. View

5.
de Witte L, Tomasik J, Schwarz E, Guest P, Rahmoune H, Kahn R . Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 2014; 154(1-3):23-9. DOI: 10.1016/j.schres.2014.02.005. View